Intellectual property law in China has steadily improved in recent years, and there has been a considerable increase in the number of patents filed in China. This article is a Q&A with Finnegan partner Ningling Wang: Ms. Wang, whose practice involves several areas, including pharmaceuticals, chemicals, medical devices, and nanotechnology, discusses the evolving climate for intellectual property and patents in China. Ms. Wang has extensive experience working with multinational big-pharma companies and domestic organizations in China. During the interview, Ms. Wang answers questions about how much the patent climate has improved in China in recent years (a lot); whether patent activity has increased (domestic China patent applications filed by foreign companies has greatly increased); and whether the Chinese government is good about encouraging companies to come in and conduct innovative research (yes). Ms. Wang concludes, however, that the growing system in China and the legal framework for venture capital arrangements still involve uncertainties.
Award/Ranking
Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked
May 28, 2026
Commentary
May 20, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Press Release
Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination
May 11, 2026
Award/Ranking
Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey
May 7, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.